$TSNDF
TerrAscend Corp. Stock $tsndf

$tsndf Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000095017024056868 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$77.52M	$80.63M
YoY Change	7.49%	16.19%
Cost Of Revenue	$39.84M	$41.90M
YoY Change	10.98%	18.04%
Gross Profit	$37.68M	$38.73M
YoY Change	4.02%	14.25%
Gross Profit Margin	48.61%	48.03%
Selling, General & Admin	$24.93M	$28.01M
YoY Change	-18.19%	1.0%
% of Gross Profit	66.16%	72.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.055M	$3.037M
YoY Change	-10.01%	-6.75%
% of Gross Profit	8.11%	7.84%
Operating Expenses	$25.06M	$32.66M
YoY Change	-23.42%	8.53%
Operating Profit	$12.62M	$6.070M
YoY Change	260.75%	59.49%
Interest Expense	-$6.541M	-$10.14M
YoY Change	-29.74%	25.09%
% of Operating Profit	-51.83%	-167.05%
Other Income/Expense, Net	$241.0K	$283.0K
YoY Change	-216.99%	1079.17%
Pretax Income	$4.492M	-$5.180M
YoY Change	-170.11%	-20.48%
Income Tax	$10.73M	$9.671M
% Of Pretax Income	238.85%
Net Earnings	-$6.237M	-$14.85M
YoY Change	-53.72%	-34.78%
Net Earnings / Revenue	-8.05%	-18.42%
Basic Earnings Per Share	-$0.03	-$0.06
Diluted Earnings Per Share	-$0.03	-$0.06
COMMON SHARES
Basic Shares Outstanding	291.5M	291.2M
Diluted Shares Outstanding	291.5M	290.6M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.12M	$24.63M
YoY Change	-5.47%	-29.54%
Cash & Equivalents	$27.38M	$22.66M
Short-Term Investments	$1.737M	$1.965M
Other Short-Term Assets	$7.884M	$6.814M
YoY Change	-35.9%	-64.18%
Inventory	$51.01M	$49.20M
Prepaid Expenses
Receivables	$16.80M	$17.01M
Other Receivables	$1.147M	$1.402M
Total Short-Term Assets	$104.8M	$97.66M
YoY Change	-1.71%	-14.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$193.3M	$194.3M
YoY Change	-7.49%	-9.24%
Goodwill	$106.9M	$106.9M
YoY Change	6.98%	11.72%
Intangibles	$212.5M	$214.1M
YoY Change	-21.17%	-12.18%
Long-Term Investments
YoY Change
Other Assets	$724.0K	$867.0K
YoY Change	-14.62%	-75.88%
Total Long-Term Assets	$555.4M	$557.9M
YoY Change	-9.7%	-5.09%
TOTAL ASSETS
Total Short-Term Assets	$104.8M	$97.66M
Total Long-Term Assets	$555.4M	$557.9M
Total Assets	$660.2M	$655.5M
YoY Change	-8.52%	-6.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.92M	$49.67M
YoY Change	-7.64%	-2.19%
Accrued Expenses	$2.330M	$1.816M
YoY Change	22.63%	-21.52%
Deferred Revenue
YoY Change
Short-Term Debt	$6.244M	$9.123M
YoY Change
Long-Term Debt Due	$9.702M	$124.5M
YoY Change	-59.91%	139.82%
Total Short-Term Liabilities	$77.46M	$199.1M
YoY Change	-41.97%	27.58%
LONG-TERM LIABILITIES
Long-Term Debt	$182.2M	$66.47M
YoY Change	-3.6%	-56.49%
Other Long-Term Liabilities	$157.7M	$140.9M
YoY Change	863.46%	789.6%
Total Long-Term Liabilities	$356.6M	$224.3M
YoY Change	21.86%	-8.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.46M	$199.1M
Total Long-Term Liabilities	$356.6M	$224.3M
Total Liabilities	$434.1M	$423.4M
YoY Change	1.87%	5.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$723.6M	-$717.4M
YoY Change	10.7%	11.83%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$224.7M	$230.6M
YoY Change
Total Liabilities & Shareholders Equity	$660.2M	$655.5M
YoY Change	-8.52%	-6.56%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$6.237M	-$14.85M
YoY Change	-53.72%	-34.78%
Depreciation, Depletion And Amortization	$3.055M	$3.037M
YoY Change	-10.01%	-6.75%
Cash From Operating Activities	$13.13M	$13.25M
YoY Change	1802.75%	57.11%
INVESTING ACTIVITIES
Capital Expenditures	$2.048M	$2.796M
YoY Change	-9.38%	11.97%
Acquisitions
YoY Change
Other Investing Activities	$643.0K	-$500.0K
YoY Change	-92.82%	-94.49%
Cash From Investing Activities	-$1.405M	-$3.423M
YoY Change	-120.97%	-70.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$12.22M
YoY Change		914.53%
Cash From Financing Activities	-7.192M	-9.599M
YoY Change	44.42%	-202.14%
NET CHANGE
Cash From Operating Activities	13.13M	13.25M
Cash From Investing Activities	-1.405M	-3.423M
Cash From Financing Activities	-7.192M	-9.599M
Net Change In Cash	4.532M	229.0K
YoY Change	88.05%	-96.34%
FREE CASH FLOW
Cash From Operating Activities	$13.13M	$13.25M
Capital Expenditures	$2.048M	$2.796M
Free Cash Flow	$11.08M	$10.46M
YoY Change	-805.8%	76.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001778129
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2024Q1	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024Q1	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	021-340690
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	TERRASCEND CORP.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A6
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 City Centre Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 501 - East Tower
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Mississauga
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L5B 1M5
CY2024Q1	dei	City Area Code CityAreaCode	717
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	610-4165
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	291507430
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22664000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22241000
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3110000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3106000
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17013000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19048000
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	1965000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	1913000
CY2024Q1	us-gaap	Inventory Net InventoryNet	49199000
CY2023Q4	us-gaap	Inventory Net InventoryNet	51683000
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3704000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4898000
CY2024Q1	us-gaap	Assets Current AssetsCurrent	97655000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	102889000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	194256000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196215000
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	284000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	337000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41488000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43440000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	214060000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215854000
CY2024Q1	us-gaap	Goodwill Goodwill	106929000
CY2023Q4	us-gaap	Goodwill Goodwill	106929000
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	867000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	854000
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	557884000
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	563629000
CY2024Q1	us-gaap	Assets Assets	655539000
CY2023Q4	us-gaap	Assets Assets	666518000
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49673000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	49897000
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4510000
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4154000
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	133668000
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	137737000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1490000
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	6446000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1816000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1244000
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2079000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2030000
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5143000
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4775000
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	737000
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	717000
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	199116000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	207000000
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	58409000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	61633000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43967000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45384000
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	383000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	407000
CY2024Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	6075000
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5162000
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7682000
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	7266000
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16919000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	17175000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1424000
CY2024Q1	tsndf	Liability On Uncertain Tax Position And Other Long Term Liabilities LiabilityOnUncertainTaxPositionAndOtherLongTermLiabilities	89455000
CY2023Q4	tsndf	Liability On Uncertain Tax Position And Other Long Term Liabilities LiabilityOnUncertainTaxPositionAndOtherLongTermLiabilities	81751000
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	224314000
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	218778000
CY2024Q1	us-gaap	Liabilities Liabilities	423430000
CY2023Q4	us-gaap	Liabilities Liabilities	425778000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	291284814
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	288327497
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	0
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	945825000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	944859000
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2197000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1799000
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-717398000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-704162000
CY2024Q1	us-gaap	Minority Interest MinorityInterest	1485000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1756000
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	232109000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240740000
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	655539000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	666518000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80633000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69398000
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	41902000
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	35498000
CY2024Q1	us-gaap	Gross Profit GrossProfit	38731000
CY2023Q1	us-gaap	Gross Profit GrossProfit	33900000
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28008000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27730000
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2215000
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2029000
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2438000
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	335000
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	32661000
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	30094000
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	6070000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3806000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1393000
CY2024Q1	tsndf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	-983000
CY2023Q1	tsndf	Gain Loss On Fair Value Of Warrants And Purchase Option Derivative Asset GainLossOnFairValueOfWarrantsAndPurchaseOptionDerivativeAsset	438000
CY2024Q1	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	8589000
CY2023Q1	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	10087000
CY2023Q1	tsndf	Transaction And Restructuring Costs TransactionAndRestructuringCosts	3000
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-285000
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	31000
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-699000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5180000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6514000
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9671000
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12664000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14851000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19178000
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3591000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14851000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-22769000
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	398000
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-347000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-14453000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-23116000
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-17055000
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-21364000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2204000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2186000
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16657000
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25302000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	2204000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	2186000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.06
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.08
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	290618567
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	267211093
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.08
CY2023Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	290618567
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	267211093
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	240740000
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1485000
CY2024Q1	tsndf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-337000
CY2024Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-4674000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-14851000
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	398000
CY2024Q1	us-gaap	Shares Outstanding SharesOutstanding	232109
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	321171000
CY2023Q1	tsndf	Stock Issued During Period Value Stock Options Warrants And Restricted Stock Units Exercised StockIssuedDuringPeriodValueStockOptionsWarrantsAndRestrictedStockUnitsExercised	81000
CY2023Q1	tsndf	Stockissuedduringperiodvalueacquisitionsadjustments Stockissuedduringperiodvalueacquisitionsadjustments	743000
CY2023Q1	tsndf	Stock Options And Warrants Issued During Period Value Legal Settlement StockOptionsAndWarrantsIssuedDuringPeriodValueLegalSettlement	593000
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1713000
CY2023Q1	tsndf	Noncontrolling Interest Increase Decrease From Capital Contributions NoncontrollingInterestIncreaseDecreaseFromCapitalContributions	-1884000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-22769000
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-347000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	299301000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14851000
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19178000
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	0
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	797000
CY2024Q1	tsndf	Accretion Expenses Net AccretionExpensesNet	-5875000
CY2023Q1	tsndf	Accretion Expenses Net AccretionExpensesNet	-4763000
CY2024Q1	tsndf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	5000000
CY2023Q1	tsndf	Depreciation And Amortization Of Intangible Assets DepreciationAndAmortizationOfIntangibleAssets	4771000
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	716000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	454000
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1485000
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1713000
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-256000
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1446000
CY2024Q1	tsndf	Gain Loss On Warrants And Derivative GainLossOnWarrantsAndDerivative	-983000
CY2023Q1	tsndf	Gain Loss On Warrants And Derivative GainLossOnWarrantsAndDerivative	438000
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-307000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1393000
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0
CY2024Q1	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	2438000
CY2024Q1	tsndf	Gain Loss On Derecognition Of Right Of Use Assets And Lease Termination GainLossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	0
CY2023Q1	tsndf	Gain Loss On Derecognition Of Right Of Use Assets And Lease Termination GainLossOnDerecognitionOfRightOfUseAssetsAndLeaseTermination	205000
CY2024Q1	tsndf	Bad Debt Expense BadDebtExpense	67000
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-285000
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	31000
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-699000
CY2024Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1954000
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-773000
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2476000
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4969000
CY2024Q1	tsndf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-1189000
CY2023Q1	tsndf	Increase Decrease In Prepaid Expenses And Other Current Assets IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets	-1203000
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-0
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-97000
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	131000
CY2024Q1	tsndf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	-3511000
CY2023Q1	tsndf	Increase Decrease In Accounts Payable And Accrued Liabilities And Other Payables IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesAndOtherPayables	6882000
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-670000
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-473000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6251000
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	198000
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	523000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25347000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26763000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25774000
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-537000
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-14000
CY2024Q1	tsndf	Increase Decrease In Uncertain Tax Position Liabilities IncreaseDecreaseInUncertainTaxPositionLiabilities	8503000
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	368000
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	11773000
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	356000
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-195000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	13251000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	10454000
CY2024Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0
CY2023Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-2020000
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13251000
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8434000
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2796000
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2497000
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	127000
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14000
CY2023Q1	us-gaap	Proceeds From Collection Of Lease Receivables ProceedsFromCollectionOfLeaseReceivables	111000
CY2023Q1	tsndf	Success Fees Related To Atc And Other Investment SuccessFeesRelatedToATCAndOtherInvestment	-738000
CY2024Q1	tsndf	Payment For Land Contracts PaymentForLandContracts	250000
CY2023Q1	tsndf	Payment For Land Contracts PaymentForLandContracts	308000
CY2024Q1	tsndf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	250000
CY2023Q1	tsndf	Cash Portion Of Consideration Paid In Acquisitions Net Of Cash Acquired CashPortionOfConsiderationPaidInAcquisitionsNetOfCashAcquired	9611000
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-3423000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-11581000
CY2024Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2023Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3423000
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11581000
CY2023Q1	tsndf	Transfer Of Employee Retention Credit TransferOfEmployeeRetentionCredit	12677000
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3137000
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2024Q1	tsndf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	0
CY2023Q1	tsndf	Proceeds From Options And Warrants Exercised ProceedsFromOptionsAndWarrantsExercised	81000
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	12215000
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1204000
CY2024Q1	tsndf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	337000
CY2023Q1	tsndf	Payments Of Capital Distribution To Noncontrolling Interest PaymentsOfCapitalDistributionToNoncontrollingInterest	1884000
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	184000
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	157000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-9599000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	9513000
CY2023Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-115000
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9599000
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9398000
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	229000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33537000
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1013000
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-551000
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	6264000
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2456000
CY2024Q1	tsndf	Payments For Lease Termination Fee PaymentsForLeaseTerminationFee	163000
CY2024Q1	tsndf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	4674000
CY2023Q1	tsndf	Business Combination Consideration Transferred Equity Issued And Liabilities Incurred BusinessCombinationConsiderationTransferredEquityIssuedAndLiabilitiesIncurred	750000
CY2023Q1	tsndf	Stock Issued During Period Value Canopy Usa Arrangement StockIssuedDuringPeriodValueCanopyUsaArrangement	593000
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1253000
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	555000
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p id="notes" style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Na</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ture of operations</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Corp. (the "Issuer") was incorporated under the Business Corporations Act (Ontario) on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">March 7, 2017</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Issuer, through its subsidiaries, TerrAscend Growth Corp. (“TerrAscend”) and its subsidiaries (collectively, the Company”), is a leading North American cannabis company. TerrAscend has vertically integrated licensed operations in Pennsylvania, New Jersey, Michigan, Maryland and California. In addition, the Company has retail operations in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada. In the United States, TerrAscend’s cultivation and manufacturing provide product selection to both the medical and legal adult-use markets. Notwithstanding the fact that various states in the United States have implemented medical marijuana laws or have otherwise legalized the use of cannabis, the use of cannabis remains illegal under U.S. federal law for any purpose, by way of the Controlled Substances Act of 1970</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company operates under one operating segment, which is the cultivation, production and sale of cannabis products.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company owns a portfolio of operating businesses, including:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend New Jersey (“TerrAscend NJ”), a majority owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_5f226f83-8429-45bf-ac2a-8815466a4b5c;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Maryland (“TerrAscend MD”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">four</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c91d44b0-10be-42ed-9fa4-5915b67e2278;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Pennsylvania (“TerrAscend PA”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">six</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6b2e06ad-881f-456c-889c-cf12699a575c;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation/processing facility;</span></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Michigan (“TerrAscend MI”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">nineteen</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_3b673507-1c3b-47a7-9766-e17e7c8a1454;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation and processing facilities;</span></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend California (“TerrAscend CA”), a wholly-owned operation with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">five</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> dispensaries, and </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_2cd57c22-1dc5-4aca-8a43-1675fb14491e;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">a</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> cultivation facility; and;</span></div></div><div style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">•</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">TerrAscend Canada Inc. (“TerrAscend Canada”) is a cannabis retailer in Ontario, Canada with a majority-owned dispensary in Toronto, Ontario, Canada ("Cookies Canada").</span></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The common shares in the capital of the Company ("Common Shares") commenced trading on the Canadian Securities Exchange ("CSE") on May 3, 2017 under the ticker symbol "TER" and continued trading on the CSE until the listing of the Common Shares on the Toronto Stock Exchange (the "TSX"). Effective July 4, 2023, the Common Shares commenced trading on the TSX under the ticker symbol "TSND". The Common Shares commenced trading on OTCQX on October 22, 2018 under the ticker symbol "TRSSF", which was subsequently changed to "TSNDF", effective July 6, 2023. The Company’s registered office is located at 77 City Centre Drive, Suite 501, Mississauga, Ontario, L5B 1M5, Canada</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
CY2024Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2017-03-07
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-717398000
CY2024Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14851000
CY2024Q1	tsndf	Trade Receivables Gross TradeReceivablesGross	26535000
CY2023Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	28403000
CY2024Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	515000
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	408000
CY2024Q1	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	887000
CY2023Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	1154000
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10924000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10917000
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17013000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19048000
CY2024Q1	tsndf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	23128000
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	214060000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	167088000
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46972000
CY2024Q1	tsndf	Trade Receivables Gross TradeReceivablesGross	26535000
CY2023Q4	tsndf	Trade Receivables Gross TradeReceivablesGross	28403000
CY2024Q1	tsndf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10924000
CY2023Q4	tsndf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10917000
CY2024Q1	tsndf	Trade Receivables Net TradeReceivablesNet	15611000
CY2023Q4	tsndf	Trade Receivables Net TradeReceivablesNet	17486000
CY2024Q1	tsndf	Trade Receivable Current TradeReceivableCurrent	12110000
CY2023Q4	tsndf	Trade Receivable Current TradeReceivableCurrent	13799000
CY2024Q1	tsndf	Trade Receivable3190 Days TradeReceivable3190Days	2545000
CY2023Q4	tsndf	Trade Receivable3190 Days TradeReceivable3190Days	2837000
CY2024Q1	tsndf	Trade Receivable Over90 Days TradeReceivableOver90Days	11880000
CY2023Q4	tsndf	Trade Receivable Over90 Days TradeReceivableOver90Days	11767000
CY2024Q1	tsndf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10924000
CY2023Q4	tsndf	Provisions For Sales Returns And Expected Credit Losses ProvisionsForSalesReturnsAndExpectedCreditLosses	10917000
CY2024Q1	tsndf	Trade Receivables Net TradeReceivablesNet	15611000
CY2023Q4	tsndf	Trade Receivables Net TradeReceivablesNet	17486000
CY2024Q1	tsndf	Number Of Customers Agreed To Payment Plan Over Ninety Days NumberOfCustomersAgreedToPaymentPlanOverNinetyDays	1
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	6446000
CY2024Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4925000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1393000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	2914000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1490000
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	1424000
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	46972000
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	237188000
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	730000
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	378000
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	17650000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18821000
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	27559000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	28451000
CY2024Q1	tsndf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	3260000
CY2023Q4	tsndf	Inventory Accessories Supplies And Consumables InventoryAccessoriesSuppliesAndConsumables	4033000
CY2024Q1	us-gaap	Inventory Net InventoryNet	49199000
CY2023Q4	us-gaap	Inventory Net InventoryNet	51683000
CY2024Q1	tsndf	Facility Held For Sale FacilityHeldForSale	67300
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230202000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	229101000
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35946000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32886000
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	194256000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196215000
CY2024Q1	tsndf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2023Q1	tsndf	Property And Equipment Capitalized Borrowing Costs PropertyAndEquipmentCapitalizedBorrowingCosts	0
CY2024Q1	us-gaap	Depreciation Depreciation	3037000
CY2023Q1	us-gaap	Depreciation Depreciation	3257000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	190216000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23128000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	190098000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22360000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	167738000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	48116000
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	48116000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	238214000
CY2023Q4	tsndf	Intangible Assets Excluding Goodwill Accumulated Amortization IntangibleAssetsExcludingGoodwillAccumulatedAmortization	22360000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	215854000
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1941000
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1514000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5257000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6835000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6820000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6740000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6740000
CY2024Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P27Y3M18D
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023Q4	us-gaap	Goodwill Goodwill	106929000
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0
CY2024Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0
CY2024Q1	us-gaap	Goodwill Goodwill	106929000
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	9123000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	11849000
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	124545000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	125888000
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	133668000
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	137737000
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	58409000
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	61633000
CY2024Q1	us-gaap	Loans Payable LoansPayable	192077000
CY2023Q4	us-gaap	Loans Payable LoansPayable	199370000
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6264000
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2456000
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3064000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3491000
CY2024Q1	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	10254000
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.1669
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	132677000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7942000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	11082000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	44483000
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1000000
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	197184000
CY2024Q1	tsndf	Number Of Finance Lease NumberOfFinanceLease	2
CY2023	tsndf	Number Of Finance Lease NumberOfFinanceLease	2
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41488000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43440000
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1816000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1244000
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43967000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45384000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	45783000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46628000
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2073000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2112000
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2079000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2030000
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	383000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	407000
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2462000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2437000
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	2034000
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	1254000
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y6M
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1143
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1143
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0947
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0947
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2034000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	6264000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16603000
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	32000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	153000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5513000
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	98000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Remainder Of Fiscal Year OperatingAndFinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	5611000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7393000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2132000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due Next Twelve Months OperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths	9525000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7158000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	134000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due Year Two OperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo	7292000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7014000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	136000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due Year Three OperatingAndFinanceLeaseLiabilityPaymentsDueYearThree	7150000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6852000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	80000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueYearFour	6932000
CY2024Q1	tsndf	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	56206000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due After Year Four OperatingAndFinanceLeaseLiabilityPaymentsDueAfterYearFour	56206000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	90136000
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2580000
CY2024Q1	tsndf	Operating And Finance Lease Liability Payments Due OperatingAndFinanceLeaseLiabilityPaymentsDue	92716000
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	44353000
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	118000
CY2024Q1	tsndf	Operating And Finance Lease Liability Undiscounted Excess Amount OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	44471000
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	45783000
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	2462000
CY2024Q1	tsndf	Operating And Finance Lease Liability OperatingAndFinanceLeaseLiability	48245000
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1485000
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1713000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16278380
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M26D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.35
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	658000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	495000
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.86
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	219312
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.67
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1256315
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	2.55
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15297753
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M20D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.48
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1917000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10437578
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M
CY2024Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.78
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	636000
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4860175
CY2024Q1	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y7M17D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.82
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1281000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	551000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.777
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.7779
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.8004
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.8016
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0318
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.035
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0285
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0321
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y3D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y3D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024Q1	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2023Q1	tsndf	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeitures Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeituresRate	0.2611
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3395000
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4263000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1078584
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3750
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	82365
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	999969
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1756000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	2374000
CY2024Q1	tsndf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-337000
CY2023	tsndf	Minority Interest Capital And Distributions Contributions MinorityInterestCapitalAndDistributionsContributions	-11622000
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2204000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8815000
CY2024Q1	us-gaap	Minority Interest MinorityInterest	1485000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1756000
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.867
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.944
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	93955000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	84485000
CY2024Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	11537000
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	10459000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	80633000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69398000
CY2024Q1	tsndf	Number Of Major Customers NumberOfMajorCustomers	0
CY2024Q1	tsndf	Loan Interest Accretion LoanInterestAccretion	8872000
CY2023Q1	tsndf	Loan Interest Accretion LoanInterestAccretion	7875000
CY2023Q1	tsndf	Employee Retention Credits And Transfer Fee EmployeeRetentionCreditsAndTransferFee	2235000
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	283000
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000
CY2024Q1	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	8589000
CY2023Q1	tsndf	Finance And Other Expenses FinanceAndOtherExpenses	10087000
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024Q1	us-gaap	Noncurrent Assets NoncurrentAssets	557884000
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	563629000
CY2024Q1	tsndf	Fair Value Assets Transfer Between Levels Amount FairValueAssetsTransferBetweenLevelsAmount	0
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	5162000
CY2024Q1	tsndf	Fair Value Gain Loss On Revaluation Of Warrants And Conversion Option FairValueGainLossOnRevaluationOfWarrantsAndConversionOption	983000
CY2024Q1	tsndf	Effects Of Movements In Foreign Exchange EffectsOfMovementsInForeignExchange	-70000
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	6075000

Files In Submission

Name	View Source	Status
0000950170-24-056868-index-headers.html	Edgar Link	pending
0000950170-24-056868-index.html	Edgar Link	pending
0000950170-24-056868.txt	Edgar Link	pending
0000950170-24-056868-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tsndf-20240331.htm	Edgar Link	pending
tsndf-20240331.xsd	Edgar Link	pending
tsndf-ex10_1.htm	Edgar Link	pending
tsndf-ex31_1.htm	Edgar Link	pending
tsndf-ex31_2.htm	Edgar Link	pending
tsndf-ex32_1.htm	Edgar Link	pending
tsndf-ex32_2.htm	Edgar Link	pending
tsndf-20240331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSNDF
TerrAscend Corp. Stock $tsndf

2024 Q2 Form 10-Q Financial Statement

#000095017024056868 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF TerrAscend Corp. Stock $tsndf

2024 Q2 Form 10-Q Financial Statement

#000095017024056868 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSNDF
TerrAscend Corp. Stock $tsndf